Skip to main content

Advertisement

Table 2 Costs, effects, and cost effectiveness of colorectal cancer screening programs over a lifetime horizon in the Ukraine

From: Cost-effectiveness of colorectal cancer screening in Ukraine

Strategy Mean cost (2012, US$) Mean effects (QALYs) Incremental cost (2012 US$) Incremental effects (QALYs) ICER Mortality decrease
Colonoscopy every 10 years 235 14.307 N/A N/A Dominant 73%
FOBT yearly 247 14.295 13 − 0.013 Dominated 61.6%
Sigmoidoscopy every 5 years with FOBT 256 14.300 21 − 0.008 Dominated 64%
No screening 404 14.218 169 − 0.084 Dominated Reference
  1. US United States, QALY quality adjusted life years, ICER incremental cost effectiveness ratios, FOBT fecal occult blood test